RNAi
Showing 51 - 71 of 71
TTR-mediated Amyloidosis Trial in United Kingdom, United States (ALN-TTRSC (revusiran) for subcutaneous administration)
Completed
- TTR-mediated Amyloidosis
- ALN-TTRSC (revusiran) for subcutaneous administration
-
Boston, Massachusetts
- +3 more
Jan 26, 2018
Atherosclerotic Cardiovascular Disease, Familial Hypercholesterolemia, Diabetes Trial in Worldwide (ALN-PCSSC, Normal Saline)
Completed
- Atherosclerotic Cardiovascular Disease
- +2 more
- ALN-PCSSC
- Normal Saline
-
Jacksonville, Florida
- +53 more
Apr 23, 2019
TTR-mediated Amyloidosis, Amyloidosis, Hereditary, Amyloid Neuropathies, Familial Trial in Worldwide (patisiran (ALN-TTR02),
Completed
- TTR-mediated Amyloidosis
- +5 more
- patisiran (ALN-TTR02)
- Sterile Normal Saline (0.9% NaCl)
-
La Mesa, California
- +51 more
Nov 18, 2018
Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC), Amyloidosis, Hereditary, Amyloid Neuropathies, Familial
Completed
- Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)
- +5 more
- Revusiran (ALN-TTRSC)
- Sterile Normal Saline (0.9% NaCl)
-
Bakersfield, California
- +60 more
Jun 22, 2018
Occult Cardiac Amyloid in the Elderly With Aortic Stenosis.
Unknown status
- Cardiac Amyloidosis
- Aortic Stenosis
- Baseline assessment
- +6 more
-
London, United Kingdom
- +1 more
Apr 17, 2018
Alpha-1 Antitrypsin Deficiency Trial in Worldwide (ARC-AAT Injection)
Withdrawn
- Alpha-1 Antitrypsin Deficiency
- ARC-AAT Injection
-
Toronto, Ontario, Canada
- +3 more
May 17, 2017
TTR-mediated Amyloidosis Trial in Leeds, London (ALN-TTRSC (revusiran), Sterile Normal Saline (0.9% NaCl))
Completed
- TTR-mediated Amyloidosis
- ALN-TTRSC (revusiran)
- Sterile Normal Saline (0.9% NaCl)
-
Leeds, United Kingdom
- +1 more
Feb 4, 2016
Hypercholesterolemia Trial in Leeds, London (ALN-PCSSC, Sterile Normal Saline (0.9% NaCl))
Completed
- Hypercholesterolemia
- ALN-PCSSC
- Sterile Normal Saline (0.9% NaCl)
-
Leeds, United Kingdom
- +1 more
Dec 16, 2015
Identifying Early Lung Cancer Cells in Malignant Pleural
Withdrawn
- Lung Cancer
- Metastatic Cancer
- microarray analysis
- +3 more
-
Cleveland, OhioCase Medical Center, University Hospitals Seidman Cancer Center,
Oct 8, 2015
Chronic Hepatitis B Trial in Melbourne (ARC-520 Injection)
Withdrawn
- Chronic Hepatitis B
- ARC-520 Injection
-
Melbourne, Victoria, AustraliaNucleus Network Ltd
Aug 12, 2015
Transthyretin (TTR)-Mediated Amyloidosis Trial in London (patisiran (ALN-TTR02), Sterile Normal Saline (0.9% NaCl))
Completed
- Transthyretin (TTR)-Mediated Amyloidosis
- patisiran (ALN-TTR02)
- Sterile Normal Saline (0.9% NaCl)
-
London, United KingdomClinical Site
May 22, 2015
Ocular Hypertension, Open Angle Glaucoma Trial in Estonia, Germany, Spain (SYL040012, Placebo)
Completed
- Ocular Hypertension
- Open Angle Glaucoma
- SYL040012
- Placebo
-
Tallin, Estonia
- +10 more
Jun 7, 2013
HIV-1 Infection Trial in Duarte (pHIV7-shI-TAR-CCR5RZ treated CD4 cells)
Terminated
- HIV-1 Infection
- pHIV7-shI-TAR-CCR5RZ treated CD4 cells
-
Duarte, CaliforniaBeckman Research Institute of City of Hope
Jan 18, 2011
HIV Infection Trial in United States (VRX496-Modified Autologous T cells)
Active, not recruiting
- HIV Infection
- VRX496-Modified Autologous T cells
-
Palo Alto, California
- +4 more
Jun 7, 2011
Liver Tissue and Blood From Individuals With Chronic Viral
Unknown status
- Hepatitis C
- +4 more
-
Toronto, Ontario, CanadaLiver Clinic, Toronto Western Hospital, UHN
Nov 29, 2005